1,478 results on '"Enomoto, Takayuki"'
Search Results
152. Author Correction: Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year
153. Dynamic changes in Japan’s prevalence of abnormal findings in cervical cytology depending on birth year
154. Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
155. Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan
156. Early metabolic change in 18F-FDG-PET by measuring the single largest lesion predicts chemotherapeutic effects and patients’ survival: PEACH study
157. Trends in Pregnancy-Associated Cervical Cancer in Japan between 2012 and 2017: A Multicenter Survey
158. Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer: An open-label multicenter phase II trial (JGOG1079)
159. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group
160. The Effect of a Web-Based Cervical Cancer Survivor’s Story on Parents' Behavior and Willingness to Consider Human Papillomavirus Vaccination for Daughters: Randomized Controlled Trial
161. Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials
162. Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081s-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081
163. Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
164. Challenges facing workstyle reform for Japanese obstetricians and gynecologists revealed from time studies
165. Additional file 2 of Fetal biometric and Doppler measurements following abdominal radical trachelectomy in the second trimester of the pregnancy
166. Additional file 1 of Fetal biometric and Doppler measurements following abdominal radical trachelectomy in the second trimester of the pregnancy
167. Biochemical analysis of intraplacental choriocarcinoma and fetomaternal transfusion
168. Gestational choriocarcinoma: Rare spinal metastasis during a viable pregnancy
169. Cervical non-squamous carcinoma: an effective combination chemotherapy of taxane, anthracycline and platinum for advanced or recurrent cases
170. Impact of histological subtype on survival of patients with surgically-treated stage IA2–IIB cervical cancer: Adenocarcinoma versus squamous cell carcinoma
171. Endometrial carcinosarcoma.
172. Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer.
173. Differential diagnosis of uterine smooth muscle tumors using diffusion-weighted imaging: correlations with the apparent diffusion coefficient and cell density
174. Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination
175. Susceptibility to male infertility: replication study in Japanese men looking for an association with four GWAS-derived loci identified in European men
176. The looming health hazard: A wave of HPV-related cancers in Japan is becoming a reality due to the continued suspension of the governmental recommendation of HPV vaccine
177. Treatment specialty‐specific characteristics and outcomes in women with vulvo‐vaginal melanoma: A JGOG‐JSCS joint study
178. Clear cell carcinoma of the endometrium
179. The ACE trial: A randomized phase II study for advanced endometrial carcinoma
180. Long‐term effectiveness of HPV vaccination against HPV infection in young Japanese women: Real‐world data
181. Long-Term Effects of Human Papillomavirus Vaccination in Clinical Trials and Real-World Data: A Systematic Review
182. 18F-FDG Fetal Dosimetry Calculated with PET/MRI
183. Can Catch-Up Vaccinations Fill the Nearly Nine-Year Void Left by Japan's Suspension of Government Recommendation for HPV Vaccination? The Expectations, Limitations, and Realities of Catch-Up Vaccinations
184. Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database
185. Phase II study of niraparib in recurrent or persistent rare fraction of gynecologic malignancies with homologous recombination deficiency (JGOG2052)
186. 嗅覚受容体のクラス選択の制御機構と嗅覚の陸棲適応
187. Correction: Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
188. The utility of anatomic diagnosis for identifying femoral nerve palsy following gynecologic surgery
189. Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer
190. Postoperative whole pelvic radiotherapy plus concurrent chemotherapy versus extended-field irradiation for early-stage cervical cancer patients with multiple pelvic lymph node metastases
191. Suspension of proactive recommendations for HPV vaccination has led to a significant increase in HPV infection rates in young Japanese women: real-world data
192. Survival and reproductive outcomes after fertility‐sparing surgery performed for borderline epithelial ovarian tumor in Japanese adolescents and young adults: Results of a retrospective nationwide study
193. Cellular and Humoral Immune Responses Induced by an HLA Class I–restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer
194. An artificial intelligence‑assisted diagnostic system improves the accuracy of image diagnosis of uterine cervical lesions
195. The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study
196. Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)
197. Efficacy and safety of standard of care with/without bevacizumab for platinum‐resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023
198. The Effect of a Web-Based Cervical Cancer Survivor’s Story on Parents' Behavior and Willingness to Consider Human Papillomavirus Vaccination for Daughters: Randomized Controlled Trial (Preprint)
199. Integrative analyses of gene expression and chemosensitivity of patient-derived ovarian cancer spheroids link G6PD-driven redox metabolism to cisplatin chemoresistance
200. Identification of Bonding Difficulties in the Peripartum Period Using the Mother-to-Infant Bonding Scale-Japanese Version and Its Tentative Cutoff Points
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.